Pregled bibliografske jedinice broj: 1192530
Enhancing Functional Recovery Through Intralesional Application of Extracellular Vesicles in a Rat Model of Traumatic Spinal Cord Injury
Enhancing Functional Recovery Through Intralesional Application of Extracellular Vesicles in a Rat Model of Traumatic Spinal Cord Injury // Frontiers in Cellular Neuroscience, 15 (2022), 795008, 18 doi:10.3389/fncel.2021.795008 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1192530 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Enhancing Functional Recovery Through
Intralesional Application of Extracellular
Vesicles in a Rat Model of Traumatic Spinal Cord
Injury
Autori
Romanelli, Pasquale ; Bieler, Lara ; Heimel, Patrick ; Škokić, Siniša ; Jakubecova, Dominika ; Kreutzer, Christina ; Zaunmair, Pia ; Smolčić, Tomislav ; Benedetti, Bruno ; Rohde, Eva ; Gimona, Mario ; Hercher, David ; Dobrivojević Radmilović, Marina ; Couillard- Despres, Sebastien
Izvornik
Frontiers in Cellular Neuroscience (1662-5102) 15
(2022);
795008, 18
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
exosomes ; inflammation ; locomotion ; motor function ; neuroimaging ; neuroregeneration ; scarring ; traumatic spinal cord injury
Sažetak
Local inflammation plays a pivotal role in the process of secondary damage after spinal cord injury. We recently reported that acute intravenous application of extracellular vesicles (EVs) secreted by human umbilical cord mesenchymal stromal cells dampens the induction of inflammatory processes following traumatic spinal cord injury. However, systemic application of EVs is associated with delayed delivery to the site of injury and the necessity for high doses to reach therapeutic levels locally. To resolve these two constraints, we injected EVs directly at the lesion site acutely after spinal cord injury. We report here that intralesional application of EVs resulted in a more robust improvement of motor recovery, assessed with the BBB score and sub- score, as compared to the intravenous delivery. Moreover, the intralesional application was more potent in reducing inflammation and scarring after spinal cord injury than intravenous administration. Hence, the development of EV-based therapy for spinal cord injury should aim at an early application of vesicles close to the lesion.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Projekti:
--UIP-2017-05-8082 - Uloga bradikinina u ishemiji mozga i mrežnice u mišjim modelima dijabetesa (BRADISCHEMIA) (Radmilović Dobrivojević, Marina) ( CroRIS)
Ustanove:
Medicinski fakultet, Zagreb
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus